Webinar
Contents
Chair
Prof. Thomas Litman
Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
Speaker(s)
Prof. Thomas Litman
Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
Topic: The ABC of MDR
Topic: The ABC of MDR
Dr. Michael M. Gottesman
Deputy Director for Intramural Research at the National Institutes of Health and Chief of the Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute.
Topic: Development of a Zebrafish model to study the role of ABC transporters at the Blood-Brain Barrier
Topic: Development of a Zebrafish model to study the role of ABC transporters at the Blood-Brain Barrier
Dr. Till Luckenbach
Senior researcher at the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, Germany.
Topic: Active transport in the context of ADME in the zebrafish embryo
Topic: Active transport in the context of ADME in the zebrafish embryo
Dr. Ian D. Kerr
Professor, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.
Topic: Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
Topic: Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
Dr. Anna Seelig
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY, USA.
Topic: A new model for allocrite transport by P-glycoprotein
Topic: A new model for allocrite transport by P-glycoprotein
Dr. Xiaozhuo Chen
Associate Investigator, Edison Biotechnology Institute Associate Professor, Microbiology Heritage College of Osteopathic Medicine, Biomedical Sciences, Ohio University. USA.
Topic: Extracellular ATP-induced and ABC transporter-mediated drug resistance in human cancer cells
Topic: Extracellular ATP-induced and ABC transporter-mediated drug resistance in human cancer cells
Dr. Antonio Tito Fojo
The Senior Investigator and Program Director, Medical Oncology Fellowship Program, National Cancer Institute, National Institutes of Health in Bethesda.
Topic: Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
Topic: Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
Professor of Medicine at Columbia University Irving Medical Center
Programme
Programme
- Time (GMT+2)
- Speakers
- Topics
- 2:00-2:10 PM
- Thomas Litman
- Welcome - The ABC of MDR
- 2:10-2:20 PM
- Michael M. Gottesman
- Development of a Zebrafish model to study the role of ABC transporters at the Blood-Brain Barrier
- 2:20-2:25 PM
- All Experts
- Discussion with the speaker (Q&A )
- 2:25-2:35 PM
- Xiaozhuo Chen
- Extracellular ATP-induced and ABC transporter-mediated drug resistance in human cancer cells
- 2:35-2:40 PM
- All Experts
- Discussion with the speaker (Q&A )
- 2:40-2:50 PM
- Anna Seelig
- A new model for allocrite transport by P-glycoprotein
- 2:50-2:55 PM
- All Experts
- Discussion with the speaker (Q&A )
- 2:55-3:05 PM
- Till Luckenbach
- Active transport in the context of ADME in the zebrafish embryo
- 3:05-3:10 PM
- All Experts
- Discussion with the speaker (Q&A )
- 3:10-3:20 PM
- Ian D. Kerr
- Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
- 3:20-3:25 PM
- All Experts
- Discussion with the speaker (Q&A )
- 3:25-3:35 PM
- Antonio Tito Fojo
- Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
- 3:35-3:40 PM
- All Experts
- Discussion with the speaker (Q&A )
- 3:40-3:50 PM
- All Experts
- Free Discussion
- 3:50-3:55 PM
- Assistant Editor
- Journal Introduction
- 3:55-4:00 PM
- Thomas Litman
- Concluding Comments
Moments
Presentation
Prof. Thomas Litman
Topic: The ABC of MDR
NaN
Dr. Till Luckenbach
Topic: Active transport in the context of ADME in the zebrafish embryo
NaN
Dr. Ian D. Kerr
Topic: Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
NaN
Dr. Anna Seelig
Topic: A new model for allocrite transport by P-glycoprotein
NaN
Dr. Antonio Tito Fojo
Topic: Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
NaN